Therapeutic Use of Valproic Acid and All-Trans Retinoic Acid in Acute Myeloid Leukemia-Literature Review and Discussion of Possible Use in Relapse after Allogeneic Stem Cell Transplantation
Even though allogeneic stem cell transplantation is the most intensive treatment for acute myeloid leukemia (AML), chemo-resistant leukemia relapse is still one of the most common causes of death for these patients, as is transplant-related mortality, i.e., graft versus host disease, infections, and...
Saved in:
Main Authors: | Øystein Bruserud (Author), Galina Tsykunova (Author), Maria Hernandez-Valladares (Author), Hakon Reikvam (Author), Tor Henrik Anderson Tvedt (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2021-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Effect of All-Trans Retinoic Acid Supplementation to Periodontitis
by: Praptiwi Hanafi, et al.
Published: (2015) -
Valproic acid attenuates immunosuppressive function of myeloid-derived suppressor cells
by: Zhiqi Xie, et al.
Published: (2018) -
All-trans retinoic acid in hematologic disorders: not just acute promyelocytic leukemia
by: Yan Chen, et al.
Published: (2024) -
Transient abnormal megakaryocytic hyperplasia secondary to all-trans retinoic acid therapy
by: Monica Jain, et al.
Published: (2012) -
Scrotal ulceration following all-trans retinoic acid therapy for acute promyelocytic leukemia
by: Illias Tazi, et al.
Published: (2011)